Obstructive sleep apnea syndrome and cardiovascular risk factors in the antihypertensive therapy “escape” phenomenon
- Authors: Mikhailova O.O.1, Elfimova E.M.1, Litvin A.Y.1,2, Chazova I.E.1
-
Affiliations:
- Chazov National Medical Research Center of Cardiology
- Pirogov Russian National Research Medical University
- Issue: Vol 95, No 1 (2023)
- Pages: 17-22
- Section: Original articles
- URL: https://journals.rcsi.science/0040-3660/article/view/133006
- DOI: https://doi.org/10.26442/00403660.2023.01.202048
- ID: 133006
Cite item
Full Text
Abstract
Aim. To assess the role of obstructive sleep apnea and other cardiovascular (CV) risk factors in the development of the antihypertensive therapy (AHT) efficacy “escape” phenomenon in patients with arterial hypertension (AH).
Materials and methods. The data of 75 patients with AH stage I–II, grades 1–3 were proceeded. All patients included in the study underwent night respiratory monitoring. After AHT prescription, blood pressure (BP) was monitored by three measurement methods (office, daily monitoring and self-control of blood pressure) – initially, in 1, 3 and 6 months after the inclusion – in order to confirm the initial therapy efficacy and to identify or exclude the “escape” phenomenon.
Results. In 36.0% of patients, the “escape” phenomenon was diagnosed in 1 or 3 months of observation. When comparing the group with the “escape” phenomenon, an initially higher level of systolic BP was revealed according to office measurements, 24-hour monitoring and self-control BP monitoring (134.0±4.7 mmHg vs 126.0±8.5 mmHg; 129.0±2.3 mmHg vs 121.0±7.7 mmHg; 131.0±8.2 mmHg vs 121.5±6.2 mmHg resp.; р<0,05). There were no differences in sleep apnea and CV risk factors between the groups. However in patients with a minimal SpO2≤85% during sleep, there were a higher levels of office systolic BP both before the AHT prescription, and during its use (157.6±10.4 mmHg vs 152.4±8.1 mmHg resp., р<0,05; 132.0±6.8 vs 127.1±8.9 mmHg resp.; р<0,05), and mean 24-hour systolic BP (125.7±5.9 vs 121.6±8.2 mmHg resp.; р<0,05) – compared with patients with a minimum SpO2>85%.
Conclusion. The higher BP level in patients with lover nocturnal hypoxemia does not allow us to exclude the delayed negative impact of obstructive sleep apnea, especially severe, on the BP profile in case of initially successful AH control.
Full Text
##article.viewOnOriginalSite##About the authors
Oksana O. Mikhailova
Chazov National Medical Research Center of Cardiology
Author for correspondence.
Email: ox.mik@mail.ru
ORCID iD: 0000-0002-3609-2504
канд. мед. наук, науч. сотр. лаб. апноэ сна отд. гипертонии
Russian Federation, MoscowEugenia M. Elfimova
Chazov National Medical Research Center of Cardiology
Email: ox.mik@mail.ru
ORCID iD: 0000-0002-3140-5030
канд. мед. наук, ст. науч. сотр. лаб. апноэ сна отд. гипертонии
Russian Federation, MoscowAleksander Yu. Litvin
Chazov National Medical Research Center of Cardiology; Pirogov Russian National Research Medical University
Email: ox.mik@mail.ru
ORCID iD: 0000-0001-5918-9969
гл. науч. сотр., рук. лаб. апноэ сна отд. гипертонии; проф. каф. поликлинической терапии лечебного фак-та
Russian Federation, Moscow; MoscowIrina E. Chazova
Chazov National Medical Research Center of Cardiology
Email: ox.mik@mail.ru
ORCID iD: 0000-0002-9822-4357
акад. РАН, проф., д-р мед. наук, рук. отд. гипертонии, зам. ген. дир. по научно-экспертной работе
Russian Federation, MoscowReferences
- Ettehad D, Emdin CA, Kiran A, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016;387(10022):957-67. doi: 10.1016/S0140-6736(15)01225-8
- Бойцов С.А., Баланова Ю.А., Шальнова С.А. Артериальная гипертония среди лиц 25–64 лет: распространенность, осведомленность, лечение и контроль. По материалам исследования ЭССЕ. Кардиоваскулярная терапия и профилактика. 2014;13(4):4-14 [Boytsov SA, Balanova YuA, Shalnova SA, et al. Arterial hypertension among individuals of 25–64 years old: prevalence, awareness, treatment and control. By the data from ECCD. Cardiovascular Therapy and Prevention. 2014;13(4):4-14 (in Russian)]. doi: 10.15829/1728-8800-2014-4-4-14
- Mills KT, Bundy JD, Kelly TN, et al. Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-Based Studies From 90 Countries. Circulation. 2016;134(6):441-50. doi: 10.1161/CIRCULATIONAHA.115.018912
- Горбунов В.М., Смирнова М.И. Современные проблемы оценки эффективности антигипертензивной терапии: скрытая неэффективность лечения и «гипертония белого халата». Рациональная фармакотерапия в кардиологии. 2009;5(3):76-82 [Gorbunov VM, Smirnovа MI. Contemporary problems of evaluation of hypertension treatment efficacy: masked hypertension and white coat hypertension. Rational Pharmacotherapy in Cardiology. 2009;5(3):76-82 (in Russian)]. doi: 10.20996/1819-6446-2009-5-3-76-82
- Frohlich ED. Classification of resistant hypertension. Hypertension. 1988;11:1524-4563. doi: 10.1161/01.hyp.11.3_pt_2.ii67
- Михайлова О.О., Литвин А.Ю., Рогоза А.Н. Влияние модифицируемых факторов риска развития сердечно-сосудистых осложнений на «ускользание» эффективности антигипертензивной терапии. Терапевтический архив. 2017;89(9):10-4 [Mikhailova OO, Litvin AY, Rogoza AN. Influence of modifiable cardiovascular risk factors on antihypertensive therapy efficiency escape. Terapevticheskii Arkhiv (Ter. Arkh.). 2017;89(9):10-4 (in Russian)]. doi: 10.17116/terarkh201789910-14
- Беленков Ю.Н., Чазова И.Е., Ратова Л.Г. Российское исследование по оптимальному снижению артериального давления (РОСА-2). Два года наблюдения. Что в итоге? Кардиоваскулярная терапия и профилактика. 2005;4(6 ч. 1):4-14 [Belenkov YuN, Chazova IE, Ratova LG. Russian Study on Optimal Blood Pressure Reduction (ROSA 2). Two-year follow-up. What is the result? Cardiovascular Therapy and Prevention. 2005;4(6 pt. I):4-14 (in Russian)].
- Mancia G, Facchetti R, Bombelli M, et al. Relationship of office, home, and ambulatory blood pressure to blood glucose and lipid variables in the PAMELA population. Hypertension. 2005;45:1072-7. doi: 10.1161/01.HYP.0000165672.69176.ed
- Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289(19):2560-72. doi: 10.1161/01.HYP.0000107251.49515.c2
- Tiffe T, Wagner M, Rücker V, et al. Control of cardiovascular risk factors and its determinants in the general population – findings from the STAAB cohort study. BMC Cardiovasc Disord. 2017;17(1):276. doi: 10.1186/s12872-017-0708-x
- Hsu HC, Chen NH, Ho WJ, Lin MH. Factors associated with undiagnosed obstructive sleep apnoea among hypertensive patients: a multisite cross-sectional survey study in Taiwan. J Clin Nurs. 2018;27(9-10):1901-12. doi: 10.1111/jocn.14366
- Чазова И.Е., Жернакова Ю.В. от имени экспертов. Клинические рекомендации. Диагностика и лечение артериальной гипертонии. Системные гипертензии. 2019;16(1):6-31 [Chazova IE, Zhernakova YuV on behalf of the experts. Clinical guidelines. Diagnosis and treatment of arterial hypertension. Systemic Hypertension. 2019;16(1):6-31 (in Russian)]. doi: 10.26442/2075082X.2019.1.19017
- Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: J Hypertens. 2018;36(10):1953-2041. doi: 10.1097/HJH.0000000000001940
- Basson MD, Newman WE, Klug MG. Correlations among visit to visit blood pressure variability and treatment with antihypertensive medication with long term adverse outcomes in a large veteran cohort. Am J Hypertens. 2021;24(10):1092-9. doi: 10.1093/ajh/hpab087
- Wakai E, Ikemura K, Kato C, Okuda M. Effect of number of medications and complexity of regimens on medication adherence and blood pressure management in hospitalized patients with hypertension. PLoS One. 2021;16(6):e0252944. doi: 10.1371/journal.pone.0252944
- Маколкин В.И. Совершенствование комбинированной терапии – путь к улучшению результатов лечения артериальной гипертонии. РМЖ. 2007;16:1238 [Makolkin VI. Enhancement of combined therapy – the way to improve the results of treatment of arterial hypertension. RMJ. 2007;16:1238 (in Russian)].
- Krousel-Wood MA, Muntner P, Islam T, et al. Barriers to and determinants of medication adherence in hypertension management: perspective of the cohort study of medication adherence among older adults. Med Clin North Am. 2009;93(3):753-69. doi: 10.1016/j.mcna.2009.02.007
- Silva RC, Silva DA, Bastos JL, et al. Anthropometric measures change and incidence of high blood pressure levels among adults: a population-based prospective study in Southern Brazil. J Hypertens. 2017;35(1):39-46. doi: 10.1097/HJH.0000000000001128
- Levin G, Kestenbaum B, Ida Chen YD, et al. Glucose, Insulin, and Incident Hypertension in the Multi-Ethnic Study of Atherosclerosis. Am J Epidemiol. 2010;172(10):1144-54. doi: 10.1093/aje/kwq266
- Halperin RO, Sesso HD, Ma J, et al. Dyslipidemia and the risk of incident hypertension in men. Hypertension. 2006;47(1):45-50. doi: 10.1161/01.HYP.0000196306.42418.0e
- Halperin RO, Gaziano JM, Sesso HD. Smoking and the risk of incident hypertension in middle-aged and older men. Am J Hypertens. 2008;21(2):148-52. doi: 10.1038/ajh.2007.36
- Cano-Pumarega I, Duran-Cantolla J, Aizpuru F, et al. Obstructive sleep apnea and systemic hypertension: longitudinal study in the general population: the Vitoria Sleep Cohort. Am J Respir Crit Care Med. 2011;184:1299-304. doi: 10.1164/rccm.201101-0130OC
- O'Connor GT, Caffo B, Newman AB, et al. Prospective study of sleep-disordered breathing and hypertension: the Sleep Heart Health Study. Am J Respir Crit Care Med. 2009;179(12):1159-64. doi: 10.1164/rccm.200712-1809OC
- Zhou L, Liu H, Wen X, et al. Effects of metformin on blood pressure in nondiabetic patients: a meta-analysis of randomized controlled trials. J Hypertens. 2017;35(1):18-26. doi: 10.1097/HJH.0000000000001119
- Cosentino F, Grant PJ, Aboyans V, et al.; ESC Scientific Document Group. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J. 2020;41(2):255-323. doi: 10.1093/eurheartj/ehz486
- Borghi C, Dormi A, Veronesi M, et al. Association between different lipid-lowering treatment strategies and blood pressure control in the Brisighella Heart Study. Am Heart J. 2004;148:285-92. doi: 10.1016/j.ahj.2004.02.003
- Chen HJ, Huang WH, Chan HL, Hwang LC. Improvement in Cardiometabolic Risk Factors During Smoking Cessation Treatment in Patients with Type 2 Diabetes: A Retrospective Cohort Study. Diabetes Metab Syndr Obes. 2021;14:1695-702. doi: 10.2147/DMSO.S303446
- Haentjens P, Van Meerhaeghe A, Moscariello A, et al. The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome: evidence from a meta-analysis of placebo-controlled randomized trials. Arch Intern Med. 2007;167:757-64. doi: 10.1001/archinte.167.8.757
- Grote L, Hedner J, Peter JH. Sleep-related breathing disorder is an independent risk factor for uncontrolled hypertension. J Hypertens. 2000;18(6):679-85. doi: 10.1097/00004872-200018060-00004
- Pedrosa RP, Drager LF, Gonzaga CC, et al. Obstructive sleep apnea: the most common secondary cause of hypertension associated with resistant hypertension. Hypertension. 2011;58:811-7. doi: 10.1161/HYPERTENSIONAHA.111.179788
- Литвин А.Ю., Михайлова О.О., Елфимова Е.М., и др. Синдром обструктивного апноэ сна и артериальная гипертония: двунаправленная взаимосвязь. Consilium Medicum. 2015;17(10):34-9 [Litvin AYu, Mikhailova OO, Elfimova EM, et al. Obstructive sleep apnea syndrome and arterial hypertension: bidirectional relationship. Consilium Medicum. 2015;17(10):34-9 (in Russian)]. doi: 10.26442/2075-1753_2015.10.34-39
- Brown J, Yazdi F, Jodari-Karimi M, et al. Obstructive Sleep Apnea and Hypertension: Updates to a Critical Relationship. Curr Hypertens Rep. 2022;24:173-84. doi: 10.1007/s11906-022-01181-w
- Parati G, Ochoa JE, Bilo G, et al. Obstructive sleep apnea syndrome as a cause of resistant hypertension. Hypertens Res. 2014;37:601-13. doi: 10.1038/hr.2014.80
- Gonçalves SC, Martinez D, Gus M, et al. Obstructive sleep apnea and resistant hypertension: a case-control study. Chest. 2007;132:1858-62. doi: 10.1378/chest.07-1170
- Wang Q, Zhang C, Jia P, et al. The association between the phenotype of excessive daytime sleepiness and blood pressure in patients with obstructive sleep apnea-hypopnea syndrome. Int J Med Sci. 2014;11(7):713-20. doi: 10.7150/ijms.7487
- Bouloukaki I, Grote L, McNicholas WT, et al. Mild obstructive sleep apnea increases hypertension risk, challenging traditional severity classification. J Clin Sleep Med. 2020;16(6):889-98. doi: 10.5664/jcsm.8354
- Hou H, Zhao Y, Yu W, et al. Association of obstructive sleep apnea with hypertension: a systematic review and meta-analysis. J Glob Health. 2018;8(1):010405. doi: 10.7189/jogh.08.010405